• LAST PRICE
    3.1200
  • TODAY'S CHANGE (%)
    Trending Down-0.1500 (-4.5872%)
  • Bid / Lots
    3.0200/ 3
  • Ask / Lots
    3.1700/ 1
  • Open / Previous Close
    3.2200 / 3.2700
  • Day Range
    Low 3.0900
    High 3.2400
  • 52 Week Range
    Low 2.8800
    High 9.4451
  • Volume
    905,808
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 3.27
TimeVolumeAFMD
09:32 ET65413.2
09:34 ET120053.21
09:36 ET12003.2
09:38 ET91783.19
09:39 ET53693.18
09:41 ET17003.175
09:43 ET14433.195
09:45 ET231433.19
09:48 ET14003.1787
09:50 ET35913.16
09:52 ET67243.175
09:54 ET49853.17
09:56 ET6003.165
09:57 ET20003.1686
09:59 ET54163.16
10:01 ET139523.15
10:03 ET7003.15
10:06 ET27043.155
10:08 ET20003.15
10:10 ET75213.145
10:12 ET54233.13
10:14 ET6003.14
10:15 ET58713.1
10:17 ET199283.11
10:19 ET58643.12
10:21 ET35463.14
10:24 ET16003.155
10:26 ET24003.16
10:28 ET40553.17
10:30 ET30483.17
10:32 ET15503.18
10:33 ET62123.19
10:35 ET61363.18
10:37 ET23003.17
10:39 ET16003.18
10:42 ET4773.175
10:44 ET34383.19
10:46 ET11743.18
10:48 ET31003.19
10:50 ET47123.17
10:51 ET3003.17
10:53 ET2003.17
10:55 ET2003.17
10:57 ET12003.16
11:00 ET2003.17
11:02 ET26903.16
11:04 ET33403.16
11:06 ET23003.145
11:08 ET2003.15
11:09 ET9643.15
11:11 ET5003.155
11:13 ET3003.16
11:15 ET99363.155
11:18 ET89233.145
11:20 ET4003.14
11:22 ET3003.14
11:26 ET10253.145
11:27 ET10003.145
11:29 ET8003.15
11:31 ET25783.15
11:33 ET4003.16
11:36 ET9003.16
11:38 ET6003.155
11:40 ET2003.16
11:42 ET4003.16
11:44 ET20853.165
11:45 ET47043.17
11:47 ET49523.175
11:49 ET13003.175
11:51 ET3003.17
11:54 ET105053.165
11:58 ET52003.165
12:00 ET111983.16
12:02 ET18433.16
12:03 ET28633.16
12:05 ET20003.16
12:07 ET8003.17
12:09 ET19653.17
12:14 ET37703.17
12:16 ET45123.175
12:18 ET4003.175
12:21 ET29233.16
12:23 ET27003.16
12:25 ET59893.16
12:27 ET2003.16
12:30 ET1003.155
12:34 ET28403.14
12:38 ET80503.14
12:39 ET1003.14
12:41 ET2003.135
12:43 ET3003.135
12:45 ET3453.14
12:50 ET46023.14
12:54 ET3003.135
12:56 ET52503.14
12:57 ET59193.15
12:59 ET54423.15
01:01 ET15003.14
01:03 ET27003.13
01:06 ET32003.125
01:08 ET24003.1277
01:10 ET49023.125
01:12 ET2003.13
01:17 ET33483.13
01:19 ET3003.13
01:21 ET30883.12
01:24 ET1003.12
01:26 ET63083.12
01:28 ET59363.12
01:30 ET20003.13
01:32 ET2003.12
01:33 ET14183.12
01:35 ET10503.12
01:37 ET22003.12
01:39 ET11003.135
01:42 ET12003.15
01:44 ET15003.15
01:46 ET1003.15
01:48 ET22493.14
01:50 ET16423.14
01:51 ET26003.15
01:53 ET7003.15
01:57 ET2003.15
02:00 ET21003.1432
02:02 ET8953.14
02:04 ET53593.14
02:06 ET30563.1427
02:09 ET52483.16
02:11 ET22003.165
02:13 ET2003.165
02:15 ET41163.145
02:18 ET3003.145
02:20 ET1003.14
02:22 ET4003.14
02:24 ET28423.15
02:26 ET4003.155
02:29 ET2003.16
02:31 ET30573.14
02:36 ET16163.15
02:38 ET36873.15
02:40 ET16993.155
02:42 ET19003.15
02:45 ET14523.14
02:47 ET26013.13
02:49 ET10003.125
02:54 ET6503.125
02:56 ET34903.12
02:58 ET4003.11
03:00 ET3003.11
03:02 ET2003.115
03:03 ET24003.125
03:05 ET8923.125
03:07 ET782473.13
03:09 ET48113.115
03:12 ET2003.115
03:16 ET5003.11
03:18 ET72463.11
03:20 ET30173.11
03:21 ET152613.1
03:23 ET110253.1
03:25 ET7983.105
03:27 ET36523.11
03:30 ET57323.1
03:32 ET60463.1
03:34 ET137773.12
03:36 ET143033.135
03:38 ET64633.14
03:39 ET54143.15
03:41 ET44973.14
03:43 ET14003.14
03:45 ET24243.135
03:48 ET3003.135
03:50 ET19973.13
03:52 ET86703.125
03:54 ET49003.125
03:56 ET37733.125
03:57 ET724443.13
03:59 ET280343.12
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAFMD
Affimed NV
477.2M
-6.1x
---
United StatesTNGX
Tango Therapeutics Inc
490.5M
-5.2x
---
United StatesIMTX
Immatics NV
453.1M
-4.4x
---
United StatesTSVT
2Seventy Bio Inc
464.6M
0.0x
---
United StatesYMAB
Y-mAbs Therapeutics Inc
463.8M
-3.9x
---
United StatesCGEM
Cullinan Oncology Inc
502.0M
-5.9x
---
As of 2022-05-24

Company Information

Affimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Company's product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research that seeks to harness the body's own immune system to fight tumor cells. Its pipeline includes AFM13, AFM13 + adoptive NK cells, AFM13 + anti-PD-1, AMF24, AMF26, AMF28 and AMF32. The Company is enrolling patients into a registration-directed study of AFM13 for CD30-positive relapsed/refractory peripheral T-cell Lymphoma and into a Phase 1/2a dose escalation/expansion study of AFM24 for the treatment of advanced EGFR-expressing solid tumors. Its preclinical product candidates include AMF26 for treating multiple myeloma, as well as AMF28 and AMF32, for treating of multiple tumor targets. In addition, the Company collaborates with Genentech to develop and commercialize certain product candidates for treating multiple cancers.

Contact Information

Headquarters
Im Neuenheimer Feld 582HEIDELBERG, Germany 69120
Phone
---
Fax
---

Executives

Independent Chairman of the Supervisory Board
Thomas Hecht
Chief Executive Officer, Member of the Management Board
Adi Hoess
Chief Financial Officer, Co-President Affimed Inc, Member of the Management Board
Angus Smith
Chief Operating Officer, Member of the Management Board
Wolfgang Fischer
Chief Scientific Officer, Member of the Management Board
Arndt Schottelius

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$477.2M
Revenue (TTM)
$43.1M
Shares Outstanding
145.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.49
EPS
$-0.51
Book Value
$1.18
P/E Ratio
-6.1x
Price/Sales (TTM)
11.1
Price/Cash Flow (TTM)
---
Operating Margin
-158.62%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.